Roivant Sciences Ltd. (ROIV): 1 insider purchase in the last two years; 4 trades disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Sep 18, 2025 | Gline Matthew Director, Officer | 3,315 | $15.07 | $50.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Nov 21, 2025 | Lisa McClain | sale | $1,001 - $15,000 |
| Nov 21, 2025 | Lisa McClain | purchase | $1,001 - $15,000 |
| Nov 21, 2025 | Lisa McClain | sale | $1,001 - $15,000 |
| Aug 13, 2025 | Lisa McClain | purchase | $1,001 - $15,000 |